Regeneron and Parabilis Medicines Forge 232 Billion Deal to Target Undruggable Proteins Recursion Pharmaceuticals Shares Slide to 52Week Low Amid Sector Headwinds Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Shifting Demand Trends Pfizer Wins Singapore Trademark Dispute with Merck Over Vaccine Brand UP Refutes Attorney General Claims Affirms Full Disclosure in Merger Documentation Marvell Stock Declines Despite Exceptional AI Demand and Upbeat Revenue Forecast GCBC Q2 2025 Earnings Solid EPS of 044 Despite Absence of Consensus Estimates ACLS Q1 2026 Earnings EPS Misses Estimate Marginally Stock Rises 29 AVD Q3 2025 Earnings Significant EPS Miss Amid Challenging Conditions TRVI Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Shares Edge Higher FLNC Q1 2026 Earnings Slightly BetterThanExpected Loss Drives Positive Market Reaction Electrovaya Inc Q1 2026 Earnings EPS Beats Estimates by 307 Stock Gains 207 Qwest Corporation 65 Notes CTBB Edge Higher Amid Steady Income Demand Expand Energy EXE Nears Resistance After Modest Decline FitLife Brands Inc FTLF Slips Amidst Market Pressure Key Support Levels in Focus T Stamp Inc IDAI Shows Modest Gains as Price Approaches Key Resistance PepsiCo PEP Edges Higher as Dividend Strength and Defensive Appeal Support Price Action Traders Shift Rate Expectations Feds Next Move Could Be a Hike as Soon as December BXP Q1 2026 Earnings Earnings Beat Estimates by Wide Margin Stock Edges Higher XOMAP Holds Steady at 2543 as Preferred Stock Maintains Parity